Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
Open Access
- 12 September 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (7) , 817-821
- https://doi.org/10.1038/sj.bjc.6603336
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the LungNew England Journal of Medicine, 2004
- Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancerEuropean Respiratory Journal, 2000
- A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancerEuropean Journal Of Cancer, 1996
- DNA Ploidy and Proliferative Activity in bcl-2 Expressed Non-small Cell Lung CancerThe Korean Journal of Internal Medicine, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)European Journal of Surgical Oncology, 1995
- The relevance of flow-cytometric DNA content in the evaluation of lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Flow cytometric nuclear DNA analysis in resected primary adenocarcinoma of the lung and applications to prognosis and adjuvant chemotherapyThe Journal of the Japanese Association for Chest Surgery, 1991
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958